ProQR Therapeutics N.V (PRQR) Shares Outstanding (Weighted Average): 2021-2025
Historic Shares Outstanding (Weighted Average) for ProQR Therapeutics N.V (PRQR) over the last 5 years, with Sep 2025 value amounting to $107.7 million.
- ProQR Therapeutics N.V's Shares Outstanding (Weighted Average) rose 27.85% to $107.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $107.7 million, marking a year-over-year increase of 27.85%. This contributed to the annual value of $84.2 million for FY2024, which is negligibly% changed negligibly from last year.
- Per ProQR Therapeutics N.V's latest filing, its Shares Outstanding (Weighted Average) stood at $107.7 million for Q3 2025, which was down 0.00% from $107.7 million recorded in Q2 2025.
- ProQR Therapeutics N.V's Shares Outstanding (Weighted Average)'s 5-year high stood at $107.7 million during Q2 2025, with a 5-year trough of $54.1 million in Q1 2021.
- Moreover, its 3-year median value for Shares Outstanding (Weighted Average) was $84.2 million (2024), whereas its average is $89.5 million.
- Data for ProQR Therapeutics N.V's Shares Outstanding (Weighted Average) shows a peak YoY skyrocketed of 36.54% (in 2022) over the last 5 years.
- Quarterly analysis of 5 years shows ProQR Therapeutics N.V's Shares Outstanding (Weighted Average) stood at $74.9 million in 2021, then increased by 0.00% to $74.9 million in 2022, then increased by 12.53% to $84.2 million in 2023, then rose by 0.00% to $84.2 million in 2024, then grew by 27.85% to $107.7 million in 2025.
- Its Shares Outstanding (Weighted Average) was $107.7 million in Q3 2025, compared to $107.7 million in Q2 2025 and $105.2 million in Q1 2025.